RISE programme led by The University of Manchester and The Christie NHS Foundation Trust and funded in part by MRC grant Poolbeg will act as the lead business partner alongside Johnson & Johnson and ...

Rotterdam, the Netherlands – 8 December 2025 – Pan Cancer T B.V., a biotech company pioneering next-generation T cell therapies for solid tumours, today announced a EUR 10 million financing to advance ...

The submission to the MHRA for use of a next generation propellant within our established beclometasone product marks the first regulatory submission for Chiesi’s carbon minimal inhaler programme ...

Fibrocor Therapeutics strengthens its clinical strategy with the appointment of four world-leading nephrology and genetics experts to its Clinical Advisory Board (CAB), reinforcing its scientific ...

First application of bio-based propionic acid brings new potential for skin health and sustainable cosmetic solutions- Propionic acid has benefits for microbiome preservation and skin balance- ...

Senzime AB (publ.) today announced that one of the leading NHS hospital trusts in the United Kingdom (UK) has ordered a total of 70 TetraGraph systems to standardize neuromuscular monitoring across ...

VANCOUVER, BC / ACCESS Newswire / December 9, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is advancing the development of a next-generation "Melt in Your ...

New data involves nonviral, targeted payload delivery to the liver using ultrasound mediated delivery (UMD), resulting in up ...

AbCellera (Nasdaq: ABCL) today announced that the Company will present at the 44th Annual J.P. Morgan Healthcare Conference ...

Planned acquisition of brelovitug for chronic hepatitis delta virus (HDV) with Breakthrough Therapy and PRIME ...

Abcuro, Inc., a late-stage clinical biotechnology company developing potentially first-in-class immunotherapies designed to ...

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, will ...